Obesity drugmaker Novo Nordisk misses Q2 profit forecast

Novo Nordisk News

Obesity drugmaker Novo Nordisk misses Q2 profit forecast
Eli LillyOperating ProfitMaggie Fick
  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 19 sec. here
  • 5 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 63%

Novo Nordisk on Wednesday posted second-quarter operating profit below expectations, raised its 2024 sales forecast but cut profit outlook, as competition...

FILE PHOTO: A view of the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen

GENEVA — A Chinese American teen is vying to become the youngest person to fly solo to all seven continents in a quest that also aims to drum up donations for research into childhood cancer.Over the last 7 days, the South Korean market has dropped 8.1%, and it is also down 4.2% over the past year, although earnings are forecast to grow by 28% annually.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

YahooFinanceCA /  🏆 47. in CA

Eli Lilly Operating Profit Maggie Fick

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

EU approves Novo Nordisk's Wegovy for heart, stroke treatmentEU approves Novo Nordisk's Wegovy for heart, stroke treatmentNovo Nordisk's (NVO) weight-loss drug Wegovy received the approval of European Union (EU) regulators to use the GLP-1 to treat heart issues and reduce stroke...
Read more »

Novo Nordisk, Eli Lilly fall on data from Roche's weight-loss pillNovo Nordisk, Eli Lilly fall on data from Roche's weight-loss pillShares of Novo Nordisk (NVO) and Eli Lilly (LLY) are sliding after Roche (ROG.SW, RBO.PA) reported promising early-stage trial data from its weight-loss pill...
Read more »

Novo Nordisk shares down after analysis finds Lilly drug leads to better weight lossNovo Nordisk shares down after analysis finds Lilly drug leads to better weight lossShares in Novo Nordisk, maker of the wildly popular obesity drug Wegovy were down 1.1% on Tuesday after the publication of a data analysis showing rival Eli ...
Read more »

North Korean officials looking for medicines for Kim's obesity-related health problems, Seoul saysNorth Korean officials looking for medicines for Kim's obesity-related health problems, Seoul saysNorth Korean leader Kim Jong Un has regained weight and is suffering from obesity-related health problems including high blood pressure and diabetes, and his officials are looking for new medicines abroad to treat them, South Korea’s spy agency told lawmakers on Monday.
Read more »

Lilly’s weight-loss drug approved in China amid race with NovoLilly’s weight-loss drug approved in China amid race with NovoEli Lilly & Co.’s Mounjaro gained Chinese regulatory approval for weight less than a month after a similar therapy from Novo Nordisk A/S, fueling competition in a nation that’s among the world’s most severely hit by obesity.
Read more »

Ozempic maker says unapproved compounded drugs being sold in CanadaOzempic maker says unapproved compounded drugs being sold in CanadaNovo Nordisk says it has filed a complaint with Health Canada regarding the promotion and sale of compounded semaglutide – a key ingredient in both Ozempic and Wegovy.
Read more »



Render Time: 2025-02-21 05:08:24